# US 2017/0318851 A1 · Composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0318851 A1
- Document ID: US20170318851A1
- Status: Published application
- Kind: A1
- Application number: 15/524,739
- Filed: 2015-11-05
- Published: 2017-11-09
- Earliest claimed: 2014-11-05
- Assignees: Optibiotix Limited
- Applicants: Optibiotix Limited
- Inventors: Stephen Patrick O'Hara
- Web page: https://patentgrep.com/patent/US20170318851A1

## CPC

- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A23C 9/1238: {using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus}
- A23C 9/1307: {Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods}
- A23C 9/1322: {Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins}
- A23C 9/133: Fruit or vegetables
- A23C 9/137: Thickening substances
- A23C 17/02: containing, or treated with, microorganisms or enzymes
- A23C 19/062: {using only lactic acid bacteria, e.g. pediococcus, leconostoc or bifidus sp., or propionic acid bacteria; Treatment with non-specified acidifying bacterial cultures}
- A23L 29/244: from corms, tubers or roots, e.g. glucomannan (starch A23L29/212)
- A23L 33/15: Vitamins
- A23L 33/16: Inorganic salts, minerals or trace elements
- A23L 33/21: Addition of substantially indigestible substances, e.g. dietary fibres
- A23L 33/30: {Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence)}
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- A61K 31/702: Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A61K 31/733: Fructosans, e.g. inulin
- A61K 31/736: Glucomannans or galactomannans, e.g. locust bean gum, guar gum
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 35/741: Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/06: Antihyperlipidemics
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/12: Antihypertensives
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A23V 2400/123: Bulgaricus
- A23V 2400/137: Delbrueckii
- A23V 2400/249: Thermophilus
- A61K 2035/115: {Probiotics}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23C: DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF (preservation thereof A23B11/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention relates to compositions for use and formulation as weight management products and in particular fermented dairy foodstuffs. The compositions generally comprise two or more of the following components: a) a microbiome modifying component; b) a satiety modifying component; and c) a metabolic modifying 5 component and at least one of the following: d) Streptococcus thermophilus CBS 139100 and Lactobacillus delbrueckii subsp. bulgaricus CBS 139099 microbial strains or mutant strains or fragments or fractions thereof; e) a combination of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus microbial strains which together, or individually, are capable of secreting polysaccharides having high levels of galactosamine 10 and no or low levels of rhamnose and glucuronic acid when grown on a dairy substrate; or f) polysaccharides formed of: i) 15-25% galactosamine; ii) 45-60% galactose; and iii) 20-30% glucose. The compositions may also be useful in the management or treatment of obesity, elevated cholesterol, diabetes, hypertension or heart disease.

## Claims

### Claim 1

A composition comprising:
a) at least two of the following components:
a microbiome modifying component;
a satiety modifying component; and
a metabolic modifying component,
and
b) at least one of following:
i) a Streptococcus thermophilus CBS 139100, Lactobacillus delbrueckii subsp. bulgaricus CBS 139099, mutant strains thereof, or fragments or fractions thereof;
ii) a combination of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus microbial strains which together, or individually, are capable of secreting polysaccharides having high levels of galactosamine and no or low levels of rhamnose and glucuronic acid when grown on a dairy substrate; or
iii) polysaccharides formed of:
15%-25% galactosamine;
45%-60% galactose; and
20%-30% glucose.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the composition comprises i) or ii) and further comprises polysaccharides having high levels of galactosamine and no or low levels of rhamnose and glucuronic acid.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the composition comprises i) or ii) and wherein the microbial strains secrete polysaccharides comprising in the range of 45-60% galactose, 20%-30% glucose and 15%-25% galactosamine, based on the total weight of secreted exopolysaccharides.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the composition comprises ii) or iii) and further comprises Streptococcus thermophilus CBS 139100 and Lactobacillus delbrueckii subsp. bulgaricus CBS 139099 microbial strains, or mutant strains thereof.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the composition comprises iii) and further comprises Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus microbial strains or fragments or fractions thereof.

### Claim 6 (depends on 5)

The composition of claim 5, wherein the strains comprise Streptococcus thermophilus CBS 139100 and Lactobacillus delbrueckii subsp. bulgaricus CBS 139099 microbial strains, or mutant strains thereof.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the microbiome modifying component further comprises one or more additional microbial strains.

### Claim at position 8

-12. (canceled)

### Claim 13 (depends on 1)

The composition of claim 1, wherein the microbiome modifying component comprises a prebiotic; the satiety modifying component comprises dietary fibre and the metabolic modifying component comprises chromium.

### Claim 14 (depends on 13)

The composition of claim 13, wherein the dietary fibre comprises glucomannan, and/or a prebiotic comprising: inulin, fructooligosaccharides (FOS), galactooligosaccharides (GOS), α-gluco-oligosaccharides, a low gas producing prebiotic or a combination thereof.

### Claim 15 (depends on 13)

The composition of claim 13, wherein the composition comprises dietary fibre in a range of 0.5 g to 15 g, chromium in a range of 50 μg to 1000 μg, and prebiotic in a range of 3 g to 30 g.

### Claim at position 12

-18. (canceled)

### Claim 19 (depends on 1)

The composition of claim 1, wherein the composition is grown on a dairy substrate, is formed as part of a dairy substrate or product, or is used as a feedstock, ingredient or additive for use with a fermented or fermentable dairy foodstuff.

### Claim 20 (depends on 19)

The composition of claim 19, wherein the fermented or fermentable dairy foodstuff is: yoghurt, cheese, crème fraiche, sour cream, buttermilk, kefir, acidophilus milk, koumiss, filmjölk and or viili.

### Claim 21 (depends on 19)

The composition of claim 19, wherein the composition further comprises: sweeteners, stabilisers, acidity regulators, water, flavourings, fats, emulsifiers, plant extracts, vegetable extracts, vitamins, minerals, phytochemicals, antioxidants, or combinations thereof.

### Claim 22 (depends on 1)

The composition of claim 1, wherein the composition comprises:
a) 50% to 90% fermented or fermentable dairy food stuff comprising and/or fermented using Streptococcus thermophilus CBS 139100 and Lactobacillus delbrueckii subsp. bulgaricus CBS 139099;
b) 1% to 10% sweetener;
c) 5% to 20% GOS;
d) up to 1.5% glucomannan;
e) up to 0.010% chromium chloride; and optionally
f) 5% to 30% fruit preparation.

### Claim 23 (depends on 1)

A method for treatment or management of weight, obesity, elevated cholesterol, diabetes, hypertension or heart disease comprising providing the composition of claim 1 to a subject in need thereof.

### Claim 24

A method of producing a composition comprising:
A.) providing two or more of the following components:
a) a microbiome modifying component;
b) a satiety modifying component;
c) a metabolic modifying component;
and
d) at least one of the following:
i) Streptococcus thermophilus CBS 139100 and Lactobacillus delbrueckii subsp. bulgaricus CBS 139099 microbial strains or mutant strains or fragments or fractions thereof;
ii) a combination of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus microbial strains which together, or individually, are capable of secreting polysaccharides having high levels of galactosamine and no or low levels of rhamnose and glucuronic acid when grown on a dairy substrate; and
iii) polysaccharides formed of:
1.) 15%-25% galactosamine;
2.) 45%-60% galactose; and
3.) 20%-30% glucose,
and
B.) mixing the chosen components from a), b) and c) together with at least one of the chosen components of d), so as to form a mixture.

### Claim 25

(canceled)

### Claim 26

A method of producing a dairy product comprising the steps:
a) fermenting an initial dairy substrate using a culture comprising:
i) Streptococcus thermophilus CBS 139100 and Lactobacillus delbrueckii subsp. bulgaricus CBS 139099; or
ii) a combination of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus microbial strains which together, or individually, are capable of secreting polysaccharides having high levels of galactosamine and no or low levels of rhamnose and glucuronic acid when grown on a dairy substrate,
so as to form a fermented dairy substrate;
b) providing two or more of the following components: a microbiome modifying component; a satiety modifying component; and a metabolic modifying component and mixing them together so as to form a mixture; and
c) forming the dairy product by:
i) dispersing or suspending the mixture throughout the fermented dairy substrate;
ii) mixing the mixture throughout the fermented dairy substrate; or
iii) placing the mixture adjacently to the fermented dairy substrate.

### Claim 27 (depends on 26)

The method of claim 26, wherein step b) further comprises providing or adding a probiotic culture to the fermented dairy substrate or mixture.

### Claim 28 (depends on 26)

The method of claim 26, wherein the satiety modifying component comprises glucomannan; the micobiome modifying component comprises a prebiotic selected from: inulin, fructooligosaccharides (FOS), galactooligosaccharides (GOS), α-gluco-oligosaccharides, a low gas producing prebiotic or a combination thereof; and the metabolic modifying component comprises chromium.

### Claim 29 (depends on 26)

The method of claim 26, wherein the method further comprises adding one or more ingredients selected from: sweeteners, stabilisers, acidity regulators, water, flavourings, fats, emulsifiers, plant extracts, vegetable extracts, vitamins, minerals, phytochemicals, antioxidants, or a combination thereof, and wherein the dairy product comprises one of the following: yoghurt, cheese, crème fraiche, sour cream, buttermilk, kefir, acidophilus milk, koumiss, filmjölk and viili.

### Claim at position 24

-31. (canceled)
